Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-05 Sale |
2023-01-06 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
24,037 | $8.02 | $192,777 | 729,429 (Direct) |
View |
| 2022-12-30 Sale |
2023-01-04 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
119,245 | $7.4555 | $889,031 | 753,466 (Direct) |
View |
| 2022-12-08 Sale |
2022-12-09 9:30 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
145,105 | $7.0276 | $1,019,736 | 888,742 (Direct) |
View |
| 2022-11-10 Sale |
2022-11-15 9:00 pm |
Roivant Sciences Ltd. | ROIV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF Holdings (UK) LLP SB INVESTMENT ADVISERS (UK) LTD 10% Owner |
4,343,919 | $4.75 | $20,633,615 | 95,031,667 (Indirect) |
View |
| 2022-11-10 Sale |
2022-11-14 9:47 pm |
Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director 10% Owner |
5,656,081 | $4.75 | $26,866,385 | 6,666,381 (Indirect) |
View |
| 2022-11-10 Sale |
2022-11-14 9:44 pm |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
5,656,081 | $4.75 | $26,866,385 | 6,718,523 (Indirect Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 9:43 pm |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
3,922,504 | $4.75 | $18,631,894 | 6,666,381 (Indirect) |
View |
| 2022-11-10 Purchase |
2022-11-14 08:40 am |
Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner |
4,000,000 | $5 | $20,000,000 | 102,849,443 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,276 | $4.4 | $84,814 | 1,164,009 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,588 | $4.4 | $6,987 | 139,354 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
15,922 | $4.4 | $70,057 | 1,049,850 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-07 4:32 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
416,667 | $6 | $2,500,002 | 73,805,331 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,741 | $3.07 | $5,345 | 140,942 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
17,392 | $3.07 | $53,393 | 1,065,772 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
21,053 | $3.07 | $64,633 | 1,183,285 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:01 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,652 | $3.71 | $6,129 | 142,683 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,530 | $3.71 | $61,326 | 1,083,164 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
20,009 | $3.71 | $74,233 | 1,204,338 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:08 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
20,455 | $4.33 | $88,570 | 1,224,347 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:02 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,686 | $4.33 | $7,300 | 144,335 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:01 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,896 | $4.33 | $73,160 | 1,099,694 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-03 Option Award |
2023-01-05 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
2,010 | $0 | 60,171 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 9:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
2,447 | $0 | 59,774 (Direct) |
View |
| 2022-12-23 Other |
2022-12-28 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,408 | $7.1 | 1,144,636 (Direct) |
View |
| 2022-12-23 Other |
2022-12-28 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,592 | $7.1 | 137,770 (Direct) |
View |
| 2022-12-23 Other |
2022-12-28 9:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,031 | $7.1 | 917,678 (Direct) |
View |
| 2022-11-20 Other |
2022-11-22 6:33 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,584 | $5 | 139,354 (Direct) |
View |
| 2022-11-20 Other |
2022-11-22 6:31 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,373 | $5 | 1,164,009 (Direct) |
View |
| 2022-11-20 Other |
2022-11-22 6:30 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,003 | $5 | 1,049,850 (Direct) |
View |
| 2022-11-09 Other |
2022-11-14 9:47 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director 10% Owner |
1,196,200 | $0 | 6,666,381 (Indirect) |
View |
| 2022-11-09 Other |
2022-11-14 9:44 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
1,196,200 | $0 | 6,718,523 (Indirect) |
View |
| 2022-11-10 Gift |
2022-11-14 9:44 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
750,000 | $0 | 6,718,523 (Direct) |
View |
| 2022-11-09 Other |
2022-11-14 9:43 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
1,196,200 | $0 | 6,666,381 (Indirect) |
View |
| 2022-10-31 Option Award |
2022-11-02 5:58 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
2,796 | $0 | 58,161 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 5:57 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
3,404 | $0 | 57,327 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
123,992 | $0 | 89,749,109 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
123,992 | $0 | 129,517,809 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
118,897 | $0 | 122,820 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
123,992 | $0 | 127,215 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 9:53 pm |
N/A 2032-09-14 |
Roivant Sciences Ltd. | ROIV | Lo Andrew Director |
123,992 | $0 | 123,992 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-25 06:06 am |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director |
3,923 | $0 | 3,923 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-25 06:06 am |
N/A 2032-07-19 |
Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director |
186,916 | $0 | 186,916 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-25 06:05 am |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Oren Ilan Director |
3,223 | $0 | 3,223 (Direct) |
View |